Thrombolytic therapy with alteplase for ischaemic stroke
Relevant BNF section: 2.10.2
Stroke is very common, with, for example, around 110,000 people each year in England alone experiencing a first or recurrent episode.1 Consequences of stroke can include disability and early death, and the condition costs the UK economy around £7billion annually.2–4 Around 70–80% of first strokes are ischaemic (i.e. due to the thromboembolic or thrombotic occlusion of an intracranial artery), and so some patients with stroke may be suitable for thrombolytic therapy.5 Here we review the evidence for such therapy in acute ischaemic stroke.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Sudlow, C., Warlow, C.
(2009). Getting the priorities right for stroke care. BMJ
338: b2083-b2083
[Full Text]
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with
Register for email alerts
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Coming soon!
The DTB archive back to 1962, volume 1, issue 1 will soon be available.
